Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...

A massive analysis recently published in the journal Aging Cell revealed that rapamycin — the immunosuppressant drug turned ...

Rapamycin may match the benefits of eating less. Scientists are now exploring its potential to support healthy aging. The ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

Dr. Ambish Mithal unpacks the world of new-age weight management drugs, their side effects, their benefits and what lies ...

Turmeric : The dried and ground rhizome (the underground stem) of the Curcuma longa plant. It is a bright yellow-orange spice ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

Metformin and lifestyle intervention was associated with delayed type 2 diabetes onset and slower diabetes progression than placebo.

Samsung Bioepis announced on the 1st that it will launch the osteoporosis treatment for menopausal women, Obodence ...

Semaglutide is linked to a reduced risk for Alzheimer’s disease-related dementia in patients with diabetes vs other antidiabetic drugs, a new study suggests.

Metformin, already prescribed to millions worldwide for diabetes, may have hidden cancer-fighting properties.

Semaglutide- the active ingredient in 'Wegovy' and 'Ozempic'- may lower dementia risk in people with type 2 diabetes. | Drug ...